Key result
Higher TAPSE/PASP is linked to ~91% lower 2-year adverse events after tricuspid repair.
Why the study?
RVFWS/PASP was proposed as a more sensitive prognostic marker than TAPSE/PASP in TR, but its role in patients undergoing TTVr remained unclear.
Does echocardiographic right ventricular-pulmonary arterial coupling (RVFWS/PASP or TAPSE/PASP) predict survival free from heart failure hospitalization in patients undergoing transcatheter tricuspid valve repair?
Cohort (n=349)
Single-blind
Yes
Does echocardiographic right ventricular-pulmonary arterial coupling (RVFWS/PASP or TAPSE/PASP) predict survival free from heart failure hospitalization in patients undergoing transcatheter tricuspid valve repair?
Answers are grounded in this paper and cite their sources.
Background: Tricuspid annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (PASP) is an established prognostic marker in tricuspid regurgitation (TR). Right ventricular free wall longitudinal strain (RVFWS)/PASP has been proposed as more sensitive prognostic markers than TAPSE/PASP in patients with TR, yet its role in patients undergoing transcatheter tricuspid valve repair (TTVr) remains unclear. The objective of the study was to evaluate and compare the prognostic value of RVFWS/PASP and TAPSE/PASP with two different vendors in symptomatic TTVr cohorts. Methods: TTVr-treated patients across three centers (2017-2023) were included. RVFWS was assessed using two vendors (A = GE EchoPAC and B = Tomtec). The primary endpoint was a composite of all-cause mortality or the first heart failure hospitalization at 2-years. Prognostic performance was assessed using Cox regression, C-statistics, and Kaplan-Meier analysis. Discrimination of both indices was not significantly different. Receiver operating characteristics-derived cutoffs identified patient subgroups with markedly different 2-year outcomes in both cohorts. Conclusions: Both RVFWS/PASP and TAPSE/PASP provided modest prognostic value after TTVr, with TAPSE/PASP demonstrating consistent independent association across vendors.
No takes yet. Share an insight, caveat, or question.
Stein et al. (2026) conducted a cohort in Symptomatic severe tricuspid regurgitation (n=349). TAPSE/PASP and RVFWS/PASP vs. Lower coupling index values was evaluated on Composite of all-cause mortality or first heart failure hospitalization at 2 years (Vendor B, TAPSE/PASP per mm/mmHg increase) (HR 0.09, 95% CI 0.03-0.26, p=<0.001). TAPSE/PASP independently predicted 2-year survival free from heart failure hospitalization after transcatheter tricuspid valve repair across platforms, outperforming RVFWS/PASP.
Synapse has enriched 10 related papers. Consider them for comparative context: